Targeting Immune Cell Metabolism for Tolerance
Clinical and Experimental Immunology · 30.10.2026
DOI: 10.1093/cei/uxag071 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 30.10.2026. Verfasst von Nicholas Jones. Beteiligte Einrichtung: Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, UK. Hauptthemen laut MEDLINE: Immune Tolerance, Autoimmune Diseases. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Targeting immune cell metabolism, or 'immunometabolism', represents an established yet rapidly evolving therapeutic strategy for the treatment of autoimmunity. From the historical use of nucleotide synthesis inhibitors, such as methotrexate and mycophenolate mofetil, to emerging approaches targeting glycolytic and mitochondrial pathways, metabolic intervention continues to offer opportunities to modulate pathogenic immune cell function. This perspective explores the evolution of immunometabolism as a therapeutic target, highlighting clinically approved metabolic modulators alongside emerging preclinical targets with potential for therapeutic translation. Emphasis is placed on exploiting the distinct metabolic dependencies of autoreactive immune cells to suppress inflammatory responses and promote immune tolerance. Consideration is also given toward the challenges associated with systemic metabolic inhibition, including broad immunosuppression and off-target tissue effects. Finally, we discuss how emerging technologies, including single-cell and spatial metabolic profiling, may facilitate the identification of autoimmune disease-specific metabolic vulnerabilities and enable more selective therapeutic interventions, potentially extending toward early disease interception and the restoration of immune tolerance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, UK.
ORCID-Profile: Nicholas Jones
Zitieren
APA
Jones, N. (2026). Targeting Immune Cell Metabolism for Tolerance. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxag071
Vancouver
Jones N. Targeting Immune Cell Metabolism for Tolerance. Clinical and Experimental Immunology. 2026. doi:10.1093/cei/uxag071
BibTeX
@article{Jones2026,
author = {Jones, Nicholas},
title = {Targeting Immune Cell Metabolism for Tolerance},
journal = {Clinical and Experimental Immunology},
year = {2026},
doi = {10.1093/cei/uxag071}
}
EUVIMED